| REVIEW |
|
| Year : 2017 | Volume
: 27
| Issue : 4 | Page : 249-257 |
Proton pump inhibitors: More indigestion than relief?
P Malavade1, S Hiremath2
1 Department of Nephrology, Narayana Hrudayalaya, Whitefield, Bengaluru, Karnataka, India; Department of Medicine, Division of Nephrology, The Ottawa Hospital, Ottawa, Canada
2 Department of Medicine, Division of Nephrology, The Ottawa Hospital, Ottawa, Canada
Correspondence Address:
P Malavade
C/O, Vijaykumar Malavde, “Anugraha” Dhundshi Nagar, Sirsi - 581 401, Karnataka, India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0971-4065.202824
Proton pump inhibitors (PPIs) are widely prescribed to treat a number of gastrointestinal (GI) disorders due to excessive acid production. While effective and safe, adverse renal effects have been increasingly described in epidemiological literature. The most well-documented adverse renal outcome is acute interstitial nephritis; however, association with overall acute kidney injury has also been recently reported. Recently, two observational studies have linked PPI use with chronic kidney disease. Finally, hypomagnesemia is another reported complication and is thought to be resulting from GI loss of magnesium. This study will critically review literature on the effect of PPIs on the kidney.
[FULL TEXT] [PDF]*
|
|
Editorial Board
